Amounts of Bile Acids and Bilirubin Removed During Single-Pass Albumin Dialysis in Patients With Liver Failure

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 5, 2011, Pages 504-506

  Benyoub, Karima ^a   Muller, Michel ^b   Bonnet, Aurélie ^a   Simon, Rémy ^a   Gazon, Mathieu ^a   Duperret, Serge ^a   Aubrun, Frédéric ^a   Viale, Jean Paul ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b Centre Hospitalier de la Region d'Annecy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; BILE ACID; BILIRUBIN; METHYLPREDNISOLONE SODIUM SUCCINATE; NORADRENALIN; TERLIPRESSIN; VITAMIN;

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ALBUMIN DIALYSIS; ALCOHOL LIVER DISEASE; CLINICAL ARTICLE; GRAM NEGATIVE SEPSIS; HEPATORENAL SYNDROME; HUMAN; LETTER; LIVER TRANSPLANTATION; PLASMA CLEARANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SINGLE PASS ALBUMIN DIALYSIS;

BILE ACIDS AND SALTS; BILIRUBIN; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 80053153643     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00980.x     Document Type: Letter

References (10)

1. Green J, Beyar R, Bomzon L, Finberg JP, Better OS. Jaundice, the circulation and the kidney. Nephron 1984;37:145-52.
2. Faubion WA, Guicciardi ME, Miyoshi H etal. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999;103:137-45.
3. Krisper P, Haditsch B, Stauber R etal. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005;43:451-7.
4. Seige M, Kreymann B, Jeschke B, Schweigart U, Kopp KF, Classen M. Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant Proc 1999;31:1371-5.
5. Sauer IM, Goetz M, Steffen I etal. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004;39:1408-14.
6. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999;31:1080-5.
7. Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT. A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. Blood Purif 2009;28:151-8.
8. Boonsrirat U, Tiranathanagul K, Srisawat N etal. Effective bilirubin reduction by single-pass albumin dialysis in liver failure. Artif Organs 2009;33:648-53.
9. Kortgen A, Rauchfuss F, Gotz M, Settmacher U, Bauer M, Sponholz C. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis-a retrospective analysis. Ther Apher Dial 2009;13:419-25.
10. Jung A, Krisper P, Haditsch B etal. Bilirubin kinetic modeling for quantification of extracorporeal liver support. Blood Purif 2006;24:413-22.